Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Zare Mehrjerdi Ali; Ahmadi Mahdie

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Basic & Clinical Cancer Research Year:2020 | Volume:12 | Issue:1 Page(s): 18-25

Download Full-Text

View:

180

Download:

Cites:

Information Journal Paper

Title

Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma

Author(s)

Zare Mehrjerdi Ali | Ahmadi Mahdie | Issue Writer Certificate

Keywords

Hodgkin’s Lymphoma;Lymphoma

Non-Hodgkin;IMP3

CD15

CD30

Abstract

Background: Hodgkin’ s lymphoma is one of the most commonly diagnosed lymphomas in Western society. Today Reed-Sternberg cells are identified by positive staining of several biomarkers. The IMP3 (insulin-like growth factor II m-RNA-binding protein 3) marker is a member of the insulin-like growth factor II mRNA binding protein family that has been suggested as a diagnostic marker in some epithelial malignancies. In this study, we aimed to evaluate the expression profile of IMP3 in Hodgkin’ s lymphoma patients and compare it with those with large cell lymphoma. Methods: In this study, patients diagnosed with Hodgkin’ s lymphoma between 2016 and 2018 were recruited. For the control group, patients diagnosed with large cell lymphoma were chosen. Paraffin blocks were collected and cut by a microtome machine. Immunohistochemical staining was performed on the slides for the IMP3 marker, using the Envision method. The color intensity was divided into four groups, and data on age, gender, staining intensity, sampling rate, and staining pattern entered at the end of the checklists. The collected data were analyzed using SPSS 19 software. The paired t-test has was employed, and a significant statistical level of 0. 05 was considered in all tests. Results: In this study, 145 patients in a wide range of 5 to 84 years (the mean age = 41 ± 17 years) were studied. Fifty-three patients were diagnosed with diffuse large B-cell lymphoma (36. 6%), 4 cases (2. 8%) with anaplastic large cell lymphoma and 88 cases with (60. 7%) Hodgkin’ s lymphoma. Among 145 patients in the current study, 143 patients (98. 6%) were positive for IMP3. IMP3 was positive in all patients with Hodgkin’ s lymphoma and anaplastic large cell lymphoma, and only 2 cases of diffuse large B-cell lymphoma were negative for this maker, in whom severe necrosis was noted. Consequently, there is not a vivid difference between Hodgkin’ s lymphoma and non-Hodgkin’ s lymphoma (p-value=0. 153) Conclusion: The marker is positive for Hodgkin’ s lymphoma with a negative background and may be used as a supplementary marker along with CD15 and CD30 to detect neoplastic cells. However, it cannot help differentiate it from large cell lymphomas because it is also positive for non-Hodgkin lymphomas.

Cites

No record.

References

Cite

APA: Copy

Zare Mehrjerdi, Ali, & Ahmadi, Mahdie. (2020). Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma. BASIC & CLINICAL CANCER RESEARCH, 12(1), 18-25. SID. https://sid.ir/paper/769973/en

Vancouver: Copy

Zare Mehrjerdi Ali, Ahmadi Mahdie. Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma. BASIC & CLINICAL CANCER RESEARCH[Internet]. 2020;12(1):18-25. Available from: https://sid.ir/paper/769973/en

IEEE: Copy

Ali Zare Mehrjerdi, and Mahdie Ahmadi, “Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma,” BASIC & CLINICAL CANCER RESEARCH, vol. 12, no. 1, pp. 18–25, 2020, [Online]. Available: https://sid.ir/paper/769973/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops